Helicobacter therapeutic
US11819546B2 · kind B2 · utility
0Cited by
5References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 27, 2021 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Aug 27, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to method of treating and/or preventing inflammation in a subject caused by bacteria that express HtrA. The present invention further relates to immunogenic compositions comprising an HtrA polypeptide or fragment thereof, as well as a therapeutic and/or prophylactic vaccine for treating or preventing disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.